Absence of protective effect of oral contraceptive use on the development of rheumatoid arthritis: A meta-analysis of observational studies

International Journal of Rheumatic Diseases

Volumn 17, Issue 7, 2014, Pages 725-737

  Chen, Qi ^a   Jin, Zhichao ^a   Xiang, Chun ^a   Cai, Qing ^b   Shi, Wentao ^a   He, Jia ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; Oral contraceptives; Rheumatoid arthritis; Risk factor

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; HUMAN; META ANALYSIS; OBSERVATIONAL STUDY; ORAL CONTRACEPTIVE USE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLISHING; RHEUMATOID ARTHRITIS; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; ARTHRITIS, RHEUMATOID; PROTECTION; RISK; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

ARTHRITIS, RHEUMATOID; CONTRACEPTIVES, ORAL, HORMONAL; DISEASE PROGRESSION; HUMANS; OBSERVATIONAL STUDY AS TOPIC; ODDS RATIO; PROTECTIVE FACTORS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84913593745     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12413     Document Type: Article

References (57)

1. Tobon GJ, Youinou P, Saraux A (2010) The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. J Autoimmun 35 (1), 10-14.
2. Kvien TK (2004) Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 22 (2 Suppl 1), 1-12.
3. Pladevall-Vila M, Delclos GL, Varas C, Guyer H, Brugues-Tarradellas J, Anglada-Arisa A (1996) Controversy of oral contraceptives and risk of rheumatoid arthritis: meta-analysis of conflicting studies and review of conflicting meta-analyses with special emphasis on analysis of heterogeneity. Am J Epidemiol 144 (1), 1-14.
4. Kaushic C, Roth KL, Anipindi V, Xiu F (2011) Increased prevalence of sexually transmitted viral infections in women: the role of female sex hormones in regulating susceptibility and immune responses. J Reprod Immunol 88 (2), 204-9.
5. Pullerits R, d'Elia HF, Tarkowski A, Carlsten H (2009) The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial. Rheumatology (Oxford) 48 (7), 785-90.
6. Sherif K (1999) Benefits and risks of oral contraceptives. Am J Obstet Gynecol 180 (6 Pt 2), S343-8.
7. Schindler AE (2013) Non-contraceptive benefits of oral hormonal contraceptives. Int J Endocrinol Metabol 11 (1), 41-7.
8. Oliver JE, Silman AJ (2006) Risk factors for the development of rheumatoid arthritis. Scand J Rheumatol 35 (3), 169-74.
9. Symmons D, Turner G, Webb R et al. (2002) The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford) 41 (7), 793-800.
10. Spector TD, Hochberg MC (1989) The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytical epidemiological studies using meta-analysis. Br J Rheumatol 28 (Suppl 1), 11-12; discussion 18-23.
11. Romieu I, Hernandez-Avila M, Liang MH (1989) Oral contraceptives and the risk of rheumatoid arthritis: a meta-analysis of a conflicting literature. Br J Rheumatol 28 (Suppl 1), 13-17; discussion 18-23
12. Wells G, Shea B, O'connell D et al. (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. In: 3rd Symposium on Systematic Reviews: Beyond the Basics, 2000, pp 3-5
13. Greenland S (1987) Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9, 1-30.
14. Zhang J, Yu KF (1998) What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280 (19), 1690-1.
15. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7 (3), 177-88.
16. Senn S (2007) Trying to be precise about vagueness. Stat Med 26 (7), 1417-30.
17. Larsson SC, Orsini N, Wolk A (2010) Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA 303 (11), 1077-83.
18. Cutolo M, Seriolo B, Villaggio B, Pizzorni C, Craviotto C, Sulli A (2002) Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Ann N Y Acad Sci 966, 131-42.
19. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D (2012) Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175 (1), 66-73.
20. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327 (7414), 557-60.
21. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC (1992) Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 327 (4), 248-54.
22. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (7109), 629-34.
23. Higgins J, Green S (2011) Cochrane handbook for systematic reviews of interventions, version 5.1.0. Updated March 2011. The Cochrane Collaboration, 2011.
24. Camacho EM, Lunt M, Farragher TM, Verstappen SM, Bunn DK, Symmons DP (2011) The relationship between oral contraceptive use and functional outcome in women with recent-onset inflammatory polyarthritis: results from the Norfolk Arthritis Register. Arthritis Rheum 63 (8), 2183-91.
25. Berglin E, Kokkonen H, Einarsdottir E, Agren A, Dahlqvist SR (2010) Influence of female hormonal factors, in relation to autoantibodies and genetic markers, on the development of rheumatoid arthritis in northern Sweden: a case-control study. Scand J Rheumatol 39 (6), 454-60.
26. Pikwer M, Bergstrom U, Nilsson JA, Jacobsson L, Berglund G, Turesson C (2009) Breast feeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis. Ann Rheum Dis 68 (4), 526-30.
27. Pedersen M, Jacobsen S, Klarlund M et al. (2006) Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Res Ther 8 (4), R133.
28. Karlson EW, Mandl LA, Hankinson SE, Grodstein F (2004) Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the nurses' health study. Arthritis Rheum 50 (11), 3458-67.
29. Doran MF, Crowson CS, O'Fallon WM, Gabriel SE (2004) The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study. J Rheumatol 31 (2), 207-13.
30. Merlino LA, Cerhan JR, Criswell LA, Mikuls TR, Saag KG (2003) Estrogen and other female reproductive risk factors are not strongly associated with the development of rheumatoid arthritis in elderly women. Semin Arthritis Rheum 33 (2), 72-82.
31. Reckner Olsson A, Skogh T, Wingren G (2001) Comorbidity and lifestyle, reproductive factors, and environmental exposures associated with rheumatoid arthritis. Ann Rheum Dis 60 (10), 934-9.
32. Pope JE, Bellamy N, Stevens A (1999) The lack of associations between rheumatoid arthritis and both nulliparity and infertility. Semin Arthritis Rheum 28 (5), 342-50.
33. Brennan P, Bankhead C, Silman A, Symmons D (1997) Oral contraceptives and rheumatoid arthritis: results from a primary care-based incident case-control study. Semin Arthritis Rheum 26 (6), 817-23.
34. Jorgensen C, Picot MC, Bologna C, Sany J (1996) Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis. Ann Rheum Dis 55 (2), 94-8.
35. Silman A, Kay A, Brennan P (1992) Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum 35 (2), 152-5.
36. van Zeben D, Hazes JM, Vandenbroucke JP, Dijkmans BA, Cats A (1990) Diminished incidence of severe rheumatoid arthritis associated with oral contraceptive use. Arthritis Rheum 33 (10), 1462-5.
37. Spector TD, Roman E, Silman AJ (1990) The pill, parity, and rheumatoid arthritis. Arthritis Rheum 33 (6), 782-9.
38. Moskowitz MA, Jick SS, Burnside S et al. (1990) The relationship of oral contraceptive use to rheumatoid arthritis. Epidemiology (Cambridge) 1 (2), 153-6.
39. Hernandez-Avila M, Liang MH, Willett WC et al. (1990) Exogenous sex hormones and the risk of rheumatoid arthritis. Arthritis Rheum 33 (7), 947-53.
40. Hazes JMW, Dijkmans BAC, Vandenbroucke JP, De Vries RRP, Cats A (1990) Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives. Arthritis Rheum 33 (2), 173-9.
41. Hazes JM, Silman AJ, Brand R, Spector TD, Walker DJ, Vandenbroucke JP (1990) Influence of oral contraception on the occurrence of rheumatoid arthritis in female sibs. Scand J Rheumatol 19 (4), 306-10.
42. Linos A, Kaklamanis E, Kontomerkos A, Vagiopoulos G, Tjonou A, Kaklamanis P (1989) Rheumatoid arthritis and oral contraceptives in the Greek female population: a case-control study. Br J Rheumatol 28 (Suppl 1), 37; discussion 42-35.
43. Koepsell T, Dugowson C, Voigt L et al. (1989) Preliminary findings from a case-control study of the risk of rheumatoid arthritis in relation to oral contraceptive use. Br J Rheumatol 28 (Suppl 1), 41; discussion 42-45.
44. Hannaford PC, Kay CR (1989) Oral contraceptives and rheumatoid arthritis: new data from the Royal College of General Practitioners' Oral Contraception Study. Br J Rheumatol 28 (Suppl 1), 36; discussion 42-35
45. Vessey MP, Villard-Mackintosh L, Yeates D (1987) Oral contraceptives, cigarette smoking and other factors in relation to arthritis. Contraception 35 (5), 457-64.
46. Darwish MJ, Armenian HK (1987) A case-control study of rheumatoid arthritis in Lebanon. Int J Epidemiol 16 (3), 420-4.
47. Vandenbroucke JP, Witteman JC, Valkenburg HA et al. (1986) Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women. JAMA 255 (10), 1299-303.
48. Del Junco DJ, Annegers JF, Luthra HS (1985) Do oral contraceptives prevent rheumatoid arthritis? JAMA 254 (14), 1938-41.
49. Allebeck P, Ahlbom A, Ljungstrom K, Allander E (1984) Do oral contraceptives reduce the incidence of rheumatoid arthritis? A pilot study using the Stockholm County medical information system. Scand J Rheumatol 13 (2), 140-6.
50. Vandenbroucke JP, Valkenburg HA, Boersma JW (1982) Oral contraceptives and rheumatoid arthritis: further evidence for a preventive effect. Lancet 2 (8303), 839-42.
51. Wingrave SJ (1978) Reduction in incidence of rheumatoid arthritis associated with oral contraceptives. Royal College of General Practitioners' Oral Contraception Study. Lancet 1 (8064), 569-71.
52. Mann C (2003) Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J 20 (1), 54-60.
53. Farmer R, Newson R, MacRae K, Lawrenson R, Tyrer F (1997) Mortality from venous thromboembolism among young women in Europe: no evidence for any effect of third generation oral contraceptives. J Epidemiol Community Health 51 (6), 630-5.
54. Wilson NM, Laursen M, Lidegaard Ø (2012) Oral contraception in Denmark 1998-2010. Acta Obstet Gynecol Scand 91 (7), 810-5.
55. Drossaers-Bakker KW, Zwinderman AH, van Zeben D, Breedveld FC, Hazes JM (2002) Pregnancy and oral contraceptive use do not significantly influence outcome in long term rheumatoid arthritis. Ann Rheum Dis 61 (5), 405-8.
56. Vandenbroucke JP, Hazes JM, Dijkmans BA, Cats A (1989) Oral contraceptives and the risk of rheumatoid arthritis: the great transatlantic divide? Br J Rheumatol 28 (Suppl 1), 1-3; discussion 18-23.
57. Esdaile JM, Horwitz RI (1986) Observational studies of cause-effect relationships: an analysis of methodologic problems as illustrated by the conflicting data for the role of oral contraceptives in the etiology of rheumatoid arthritis. J Chronic Dis 39 (10), 841-52.